Kasvu Therapeutics
Kasvu Therapeutics develops neuroplastogens to treat brain disorders by improving neural connectivity. They use AI-powered supercomputing and structure-based drug design to discover small molecules that engage the TrkB receptor to boost neuroplasticity. It targets CNS conditions such as neuropsychiatric and neurodegenerative diseases. The approach uses proprietary AI, machine learning, and biomolecular simulations to progress toward clinical proof.
Kasvu Therapeutics
Kasvu Therapeutics develops neuroplastogens to treat brain disorders by improving neural connectivity. They use AI-powered supercomputing and structure-based drug design to discover small molecules that engage the TrkB receptor to boost neuroplasticity. It targets CNS conditions such as neuropsychiatric and neurodegenerative diseases. The approach uses proprietary AI, machine learning, and biomolecular simulations to progress toward clinical proof.